Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ponatinib: Accelerated Disapproval.

Ponatinib: Accelerated Disapproval. Oncologist. 2015 Aug; 20(8):847-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.